A detailed history of Invesco Ltd. transactions in Meira G Tx Holdings PLC stock. As of the latest transaction made, Invesco Ltd. holds 12,701 shares of MGTX stock, worth $77,857. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,701
Previous 12,166 4.4%
Holding current value
$77,857
Previous $51,000 1.96%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$3.88 - $5.23 $2,075 - $2,798
535 Added 4.4%
12,701 $52,000
Q2 2024

Aug 13, 2024

SELL
$4.21 - $5.81 $27,899 - $38,502
-6,627 Reduced 35.26%
12,166 $51,000
Q1 2024

May 14, 2024

BUY
$5.78 - $7.33 $6,242 - $7,916
1,080 Added 6.1%
18,793 $114,000
Q4 2023

Feb 12, 2024

BUY
$3.6 - $7.15 $19,548 - $38,824
5,430 Added 44.21%
17,713 $124,000
Q3 2023

Nov 13, 2023

BUY
$4.79 - $7.19 $129 - $194
27 Added 0.22%
12,283 $60,000
Q2 2023

Aug 11, 2023

BUY
$5.19 - $8.07 $63,608 - $98,905
12,256 New
12,256 $82,000
Q4 2022

Feb 13, 2023

SELL
$5.8 - $8.98 $29 - $44
-5 Reduced 0.04%
11,227 $73,000
Q3 2022

Nov 14, 2022

SELL
$7.55 - $11.25 $528 - $787
-70 Reduced 0.62%
11,232 $94,000
Q2 2022

Aug 15, 2022

BUY
$6.8 - $14.23 $340 - $711
50 Added 0.44%
11,302 $86,000
Q1 2022

May 16, 2022

BUY
$13.42 - $23.38 $3,220 - $5,611
240 Added 2.18%
11,252 $156,000
Q4 2021

Feb 14, 2022

SELL
$12.78 - $23.74 $26,173 - $48,619
-2,048 Reduced 15.68%
11,012 $261,000
Q3 2021

Nov 15, 2021

BUY
$11.73 - $16.08 $14,463 - $19,826
1,233 Added 10.43%
13,060 $172,000
Q2 2021

Aug 17, 2021

BUY
$12.85 - $16.2 $151,976 - $191,597
11,827 New
11,827 $184,000
Q1 2020

May 15, 2020

SELL
$9.31 - $21.24 $448,760 - $1.02 Million
-48,202 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$13.91 - $21.48 $670,489 - $1.04 Million
48,202 New
48,202 $965,000

Others Institutions Holding MGTX

About MeiraGTx Holdings plc


  • Ticker MGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,010,700
  • Market Cap $276M
  • Description
  • MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...
More about MGTX
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.